Skip to main content

Table 2 Demographic and baseline clinical characteristics of HIV-infected patients admitted to the ICU, stratified according to immunovirological statuses

From: Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status

  

Patients with complete immunovirological status available

 

Total

n = 76

  

CD4 high

CD4 low

CD4 low

CD4 high

p value

 

n = 98

VL high

VL high

VL low

VL low

 

Variable (n,%)

 

n = 14

n = 40

n = 10

n = 12

 

Males

69 (70.4)

8 (57.1)

28 (70)

8 (80)

10 (83.3)

0.496

Age, yr (mean ± SD)

43.1 (10.7)

42.2 (8.5)

40.1 (8.7)

46.8 (16.7)

54.7 (10.5)

<0.001

Time since HIV diagnosis

  

Less than 6 months

17 (17.3)

1 (7.1)

8 (20)

1 (10)

0 (0)

 

Intermediate

14 (14.3)

4 (28.6)

6 (15)

2 (20)

2 (16.7)

0.62

More than 5 years

67 (68.4)

9 (64.3)

26 (65)

7 (70)

10 (83.3)

 

HIV diagnosis in ICU

8 (8.2)

0 (0)

6 (15)

0 (0)

0 (0)

0.217

Comorbidities

      

HbsAg-positive.

14 (14.3)

3 (21.4)

6 (15)

0 (0)

1 (8.3)

0.532

Anti-hepatitis C virus positive

30 (30.6)

10 (71.4)

7 (17.5)

4 (40)

2 (16.7)

0.001

HbsAg + antihepatitis C virus positive

7 (7.1)

3 (21.4)

2 (5)

0 (0)

0 (0)

0.117

Alcohol abuse

29 (30)

8 (57.1)

13 (32.5)

2 (20)

2 (16.7)

0.137

Tobacco

30 (31)

8 (57.1)

15 (37.5)

1 (10)

3 (25)

0.099

Past medical history of cancer

13 (12.6)

0 (0)

3 (7.5)

4 (40)

2 (16.7)

0.016

Main reasons for ICU admission

  

Acute respiratory failure

38 (38.8)

8 (57.1)

16 (40)

2 (20)

3 (25)

 

Sepsis

11 (11.2)

1 (7.1)

3 (7.5)

1 (10)

2 (16.7)

0.749

Severe neurologic disorders

25 (25.5)

2 (14.3)

11 (27.5)

4 (40)

3 (25)

 

Miscellaneous

24 (24.5)

3 (21.5)

10 (25)

3 (30)

6 (33.3)

 

Opportunistic infections

      

No opportunistic infection

73

14 (100)

25 (62.5)

10 (100)

11 (91.7)

0.002

Pneumocystis jirovecii pneumonia

11 (11.2)

0 (0)

5 (12.5)

0 (0)

1 (8.3)

 

Tuberculosis

1 (1)

0 (0)

1 (1)

0 (0)

0 (0)

-

Toxoplasmosis

6 (6.1)

0 (0)

4 (10)

0 (0)

0 (0)

 

Cryptococcosis

3 (3)

0 (0)

2 (5)

0 (0)

0 (0)

 

Reactivation of cytomegalovirus (antigenemia positive)

15 (15.3)

0 (0)

10 (25)

0 (0)

1 (8.3)

0.054

ICU data

  

SAPS II score (median)

49.5

52

48.5

56

49.5

0.522

APACHE II score (median)

17.5

16.5

18

20

14.5

0.509

Albumin, g/dL (median)

26.1

32.1

28.8

30.7

42.1

0.169

Mechanical ventilation in the first day

59 (60.2)

10 (71.4)

19 (47.5)

8 (80)

8 (66.7)

0.176

  1. APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acute Physiology Score; ART, antiretroviral therapy; HIV, human immunodeficiency virus; HCV, hepatitis C virus; HbsAg, hepatitis B virus surface antigen; ICU, intensive care unit; CD4, lymphocyte T CD4(+); CD4high, ≥200 cell/mm3; CD4low, <200 cell/mm3; VL, viral load; VLhigh, ≥103 copies/ml; VLlow, <103 copies/ml; HAART, highly active antiretroviral therapy.
  2. *p is significant.